Financial PerformancePaySign Inc. reported results that beat consensus on revenue and core adjusted EBITDA, driven by the acquisition of rights to manage payments for additional plasma centers.
Growth OutlookPaysign's growth outlook remains very positive driven by its Pharma Patient Affordability business segment and a recent large new business award within the Plasma segment.
Strategic ExpansionPaysign announced the acquisition of Gamma Innovation, which offers technology-driven donor engagement app, a specialized CRM platform, and donor management solutions for the Plasma segment.